Your browser doesn't support javascript.
loading
Impact of dipeptidyl peptidase-4 inhibitors on glucose-dependent insulinotropic polypeptide in type 2 diabetes mellitus: a systematic review and meta-analysis.
Chai, Shangyu; Zhang, Ruya; Carr, Richard David; Deacon, Carolyn F; Zheng, Yiman; Rajpathak, Swapnil; Chen, Jingya; Yu, Miao.
  • Chai S; Merck Research Laboratories (MRL) Global Medical Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China.
  • Zhang R; Merck Research Laboratories (MRL) Global Medical Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China.
  • Carr RD; Hatter Cardiovascular Institute, University College London, London, United Kingdom.
  • Deacon CF; School of Biomedical Sciences, Ulster University, Coleraine, United Kingdom.
  • Zheng Y; School of Biomedical Sciences, Ulster University, Coleraine, United Kingdom.
  • Rajpathak S; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Chen J; Merck Research Laboratories (MRL) Global Medical Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China.
  • Yu M; Merck Research Laboratories, Merck & Co., Inc., Rahway, NJ, United States.
Front Endocrinol (Lausanne) ; 14: 1203187, 2023.
Article en En | MEDLINE | ID: mdl-37635974

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article